Hai Seikan, Kubo Shoji, Shuto Taichi, Tanaka Hiromu, Takemura Shigekazu, Yamamoto Takatsugu, Kanazawa Akishige, Ogawa Masao, Hirohashi Kazuhiro, Wakasa Kenichi
Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Abeno-ku, Japan.
Surg Today. 2006;36(4):390-4. doi: 10.1007/s00595-005-3167-4.
Sporadic cases of hepatocellular carcinoma (HCC) originating from nonalcoholic steatohepatitis (NASH) have recently been reported. Thus, we investigated the prevalence of NASH in patients with HCC. A review of the clinical records of 481 patients who underwent liver resection for HCC in our department between January 1991 and December 2003 revealed only two (0.4%) patients with HCC associated with NASH. Both of these patients had noninsulin-dependent diabetes mellitus, and neither had a history of alcohol consumption or blood transfusion. All serologic markers for hepatitis B and C viruses were negative. Histological examination of the noncancerous hepatic tissue revealed NASH with moderate hepatic fibrosis in one patient and cirrhosis in the other. Thus, clinical follow-up and screening for HCC should be done for patients with hepatic fibrosis caused by NASH, even though this form of hepatitis is an uncommon cause of HCC.
最近有报告称出现了源自非酒精性脂肪性肝炎(NASH)的散发性肝细胞癌(HCC)病例。因此,我们对HCC患者中NASH的患病率进行了调查。回顾1991年1月至2003年12月间在我科接受HCC肝切除术的481例患者的临床记录,发现仅有两例(0.4%)HCC患者合并NASH。这两名患者均患有非胰岛素依赖型糖尿病,且均无饮酒或输血史。所有乙肝和丙肝病毒血清学标志物均为阴性。对非癌性肝组织的组织学检查显示,一名患者为伴有中度肝纤维化的NASH,另一名患者为肝硬化。因此,即使这种形式的肝炎是HCC的罕见病因,对于由NASH引起肝纤维化的患者也应进行HCC的临床随访和筛查。